公开(公告)号：US20220184199A1

公开(公告)日：2022-06-16

申请号：US17601949

申请日：2020-04-06

申请人： Pfizer Inc.

发明人： Annaliesa Sybil Anderson ,  Isis Kanevsky ,  Farid Latif Khan ,  Charles Harold Jones ,  John Michael McLaughlin

IPC分类号： A61K39/09

摘要： The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunogenic compositions and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said novel immunogenic compositions.